EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Klinische Studie (Phase I)Open Access · CC BY-NC-ND 4.0

Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease

Jin Woo Chang, Han Kyu Na, Kyung Won Chang, Chan Wook Park, Do-Hun Kim, Sanghyun Park, Chul-Yong Park, Jang Hyeon Eom, Seung Taek Nam, Ki-Sang Jo, Mi-Young Jo, Sung Kyoung Choi und 11 weitere

Cell · 2025-12 · 188 (25) · 7036-7048.e11

DOI: 10.1016/j.cell.2025.09.010 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Cell, 2025-12. Verfasst von Jin Woo Chang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Korea University Anam Hospital, Seoul 02841, Republic of Korea. Hauptthemen laut MEDLINE: Parkinson Disease, Dopaminergic Neurons, Human Embryonic Stem Cells, Stem Cell Transplantation. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, South Korea, Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDopaminergic NeuronsHuman Embryonic Stem CellsStem Cell TransplantationHumansMaleMiddle AgedFemaleAgedPutamenPositron-Emission TomographyAdult

Stichwörter der Autor:innen

Parkinson’s diseasecell transplantationdopamine neuronsdopamine progenitordopaminergic differentiationdose-escalation trialhuman embryonic stem cellsstem-cell based therapy

Autor:innen und Institutionen

  • Department of Neurosurgery, Korea University Anam Hospital, Seoul 02841, Republic of Korea.
  • Department of Neurology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
  • Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
  • Department of Neurology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; Department of Physiology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
  • Department of Physiology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; S. Biomedics Co., Ltd., Seoul 04797, Republic of Korea.
  • Department of Physiology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science and ICT, South Korea
  • Ministry of Health and Welfare

Zitieren

APA

Chang, J. W., Na, H. K., Chang, K. W., Park, C. W., Kim, D. H., Park, S., Park, C. Y., Eom, J. H., Nam, S. T., Jo, K. S., Jo, M. Y., Choi, S. K., Hur, H. J., Kim, S., Kim, M., Kim, D. S., Hwang, D. Y., Kim, M. S., Jung, I., …, & Kim, D. W. (2025). Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease. Cell, 188(25), 7036-7048.e11. https://doi.org/10.1016/j.cell.2025.09.010

Vancouver

Chang JW, Na HK, Chang KW, Park CW, Kim DH, Park S, et al. Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease. Cell. 2025;188(25):7036-7048.e11. doi:10.1016/j.cell.2025.09.010

BibTeX
@article{Chang2025,
  author = {Chang, Jin Woo and Na, Han Kyu and Chang, Kyung Won and Park, Chan Wook and Kim, Do-Hun and Park, Sanghyun and Park, Chul-Yong and Eom, Jang Hyeon and Nam, Seung Taek and Jo, Ki-Sang and Jo, Mi-Young and Choi, Sung Kyoung and Hur, Hye-Jin and Kim, Sarang and Kim, Minseok and Kim, Dae-Sung and Hwang, Dong-Youn and Kim, Myoung Soo and Jung, Inkyung and Kim, Jongwan and Cho, Myung Soo and Lee, Phil Hyu and Kim, Dong-Wook},
  title = {Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease},
  journal = {Cell},
  year = {2025},
  volume = {188},
  number = {25},
  pages = {7036--7048.e11},
  doi = {10.1016/j.cell.2025.09.010}
}
Kostenlos starten →